[go: up one dir, main page]

CY1111112T1 - Συνθεση επιβραδυνσης του μεταβολισμου της αλκοολης - Google Patents

Συνθεση επιβραδυνσης του μεταβολισμου της αλκοολης

Info

Publication number
CY1111112T1
CY1111112T1 CY20111100055T CY111100055T CY1111112T1 CY 1111112 T1 CY1111112 T1 CY 1111112T1 CY 20111100055 T CY20111100055 T CY 20111100055T CY 111100055 T CY111100055 T CY 111100055T CY 1111112 T1 CY1111112 T1 CY 1111112T1
Authority
CY
Cyprus
Prior art keywords
present
alcohol
composition
people
food composition
Prior art date
Application number
CY20111100055T
Other languages
English (en)
Inventor
Markus Graf Von Matuschka-Greiffenclau
Hans Peter Jander
Original Assignee
Matuschka-Greiffenclau, Markus, Graf V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matuschka-Greiffenclau, Markus, Graf V. filed Critical Matuschka-Greiffenclau, Markus, Graf V.
Publication of CY1111112T1 publication Critical patent/CY1111112T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μια σύνθεση, συγκεκριμένα μια διατροφική σύνθεση ή διαιτητικό συμπλήρωμα η οποία είναι δραστική σε σχέση με την υποστήριξη και/ή την επιβράδυνση μιας διαδικασίας αποδόμησης της αλκοόλης εντός του ανθρώπινου σώματος. Η παρούσα εφεύρεση αντιμετωπίζει ειδικώς το πρόβλημα της ταχείας αποδόμησης της αλκοόλης, ήτοι του μεταβολισμού της αλκοόλης όπως μπορεί να λάβει χώρα στα περισσότερα άτομα γενετικής δομής μη Καυκάσιου τύπου. Από αυτή την άποψη, ένα αντικείμενο της παρούσας εφεύρεσης είναι να επιτυγχάνονται διαλύματα τα οποία παρέχουν μια μείωση του φυσιολογικού στρες σε σχέση με την κατανάλωση αλκοόλης, συγκεκριμένα για άτομα με προδιάθεση προς την ταχεία αλκοολική αποδόμηση. Σύμφωνα με την παρούσα εφεύρεση αυτό το αντικείμενο επιτυγχάνεται με μια διατροφική σύνθεση ή διαιτητικό συμπλήρωμα που περιέχει τις ακόλουθες ουσίες: δεξτρόζη, βιταμίνη C, L-γλουταμίνη, κυστεΐνη, ριβοφλαβίνη, ηλεκτρικό οξύ, φουμαρικό οξύ, και συνένζυμο Q10, όλες οι ουσίες υπό φυσιολογικώς σχετικές δόσεις συγκεκριμένα όπως αποκαλύπτεται.
CY20111100055T 2004-02-17 2011-01-18 Συνθεση επιβραδυνσης του μεταβολισμου της αλκοολης CY1111112T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04003529 2004-02-17
EP05726408A EP1720610B1 (en) 2004-02-17 2005-02-17 Alcohol metabolism moderating composition

Publications (1)

Publication Number Publication Date
CY1111112T1 true CY1111112T1 (el) 2015-06-11

Family

ID=34854555

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100055T CY1111112T1 (el) 2004-02-17 2011-01-18 Συνθεση επιβραδυνσης του μεταβολισμου της αλκοολης

Country Status (19)

Country Link
US (1) US20070218106A1 (el)
EP (1) EP1720610B1 (el)
JP (3) JP2007522254A (el)
KR (1) KR20070034459A (el)
CN (1) CN1946456B (el)
AT (1) ATE491497T1 (el)
AU (1) AU2005211936B2 (el)
CA (1) CA2555099C (el)
CY (1) CY1111112T1 (el)
DE (1) DE602005025313D1 (el)
DK (1) DK1720610T3 (el)
EA (1) EA011721B1 (el)
ES (1) ES2355905T3 (el)
HR (1) HRP20110046T1 (el)
PL (1) PL1720610T3 (el)
PT (1) PT1720610E (el)
SI (1) SI1720610T1 (el)
UA (1) UA88780C2 (el)
WO (1) WO2005077464A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI121528B (fi) 2000-10-30 2010-12-31 Biohit Oyj Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
FI122914B (fi) 2005-04-01 2012-08-31 Biohit Oyj Elintarvikekoostumus asetaldehydin sitomiseksi suussa ja ruoansulatuskanavassa ja menetelmä koostumuksen valmistamiseksi
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
SI1909600T1 (sl) * 2005-07-29 2012-07-31 Tima Foundation Zmes za nadzor metabolizma alkohola in za zmanjšanje nevarnosti z alkoholom induciranih bolezni
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
EP2117596B1 (en) * 2006-12-15 2018-01-03 TIMA Foundation Antioxidant composition and its use in diabetes
EP1932542A1 (en) * 2006-12-15 2008-06-18 TIMA Foundation Antioxidant composition and its use in diabetes
JP2010115124A (ja) * 2008-11-11 2010-05-27 Iwata Kagaku Kogyo Kk 血中エタノール濃度を減少させるための黒糖醗酵生産物
WO2012027603A2 (en) * 2010-08-26 2012-03-01 Clarity Products, Limited Liability Company Therapeutic consumable compositions for reduction of facial flush effect incident to alcohol consumption in persons with deficient activity of the aldehyde dehydrogenase gene-aldh2
HK1201693A1 (en) 2011-11-15 2015-09-11 Tima Foundation Composition for protection against cell-damaging effects
FI129157B (en) 2012-05-28 2021-08-13 Biohit Oyj Composition for use in reducing the incidence of or preventing severe headaches
RU2555769C1 (ru) * 2014-04-24 2015-07-10 Омнифарма Юроп Лимитед Диетическая добавка для профилактики алкогольной интоксикации и облегчения похмельного синдрома
WO2020055809A1 (en) 2018-09-11 2020-03-19 Powin Energy Corporation Modular battery stack and support system
CN112868971A (zh) * 2021-02-26 2021-06-01 高涵 一种具有缓解宿醉醒酒护胃功能的固体饮料及其制备工艺
CN117730986A (zh) * 2023-11-21 2024-03-22 新疆丝路本草中药有限公司 红花蜂蜜，或红花蜂蜜提取物在提高adh和aldh活性中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496548A (en) * 1983-02-04 1985-01-29 Moldowan Mervin J Composition and method for reducing hangover
EP0185117A1 (de) * 1984-12-21 1986-06-25 IPEX Getränke-Herstellungs- und Vertriebsgesellschaft mbH Getränk
PH22818A (en) * 1986-02-18 1989-01-19 Takeda Chemical Industries Ltd Composition and method for reducing acetaldehyde toxicity
JP2560808B2 (ja) * 1988-11-02 1996-12-04 味の素株式会社 アミノ酸及びペッパー抽出物含有酒類
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
JP3051413B2 (ja) * 1989-07-20 2000-06-12 アルバート・ティー・ナイトー 血液脳関門を通過する物質
JPH04342528A (ja) * 1991-05-17 1992-11-30 Toyama Chem Co Ltd アルコール代謝およびアセトアルデヒド代謝促進剤
US5559152A (en) * 1992-07-06 1996-09-24 Komissarova; Irina A. Pharmaceutical composition having antiacoholic activity
JPH0733653A (ja) * 1993-06-25 1995-02-03 Suntory Ltd アセトアルデヒド毒性の抑制剤
US5475031A (en) * 1993-09-03 1995-12-12 Livingston; William H. Discovery of a valuable property for succinic acid and other intermediary metabolites
GB9526741D0 (en) * 1995-12-30 1996-02-28 Sobering Thoughts Ltd Product for combatting dehydration
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
FR2748935A1 (fr) * 1996-05-23 1997-11-28 Clergeaud Jean Solution buvable favorisant la baisse du taux d'alcoolemie
US6667063B2 (en) * 1998-06-10 2003-12-23 Albert Crum Nutritional or therapeutic supplement and method
US20020006910A1 (en) * 2000-05-18 2002-01-17 Dmitri Miasnikov Means for allaying drunkenness, preventing and removing alcohol intoxication and hangover syndrome and a method for allaying drunkenness, preventing and removing alcohol intoxication and hangover syndrome by using this means
US6630158B2 (en) * 2000-10-31 2003-10-07 Stiefel Laboratories, Inc. Dietary supplement composition and method for improving and maintaining healthy skin
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
AUPR626101A0 (en) * 2001-07-10 2001-08-02 Mcgregor, Neil A composition and uses therefor
JP4119640B2 (ja) * 2001-10-26 2008-07-16 株式会社大塚製薬工場 飲酒時の不快症状軽減剤
US6936283B2 (en) * 2003-07-25 2005-08-30 Langeland Bjoern T. Composition for stimulation of specific metallo-enzymes

Also Published As

Publication number Publication date
JP2012092120A (ja) 2012-05-17
HK1092746A1 (en) 2007-02-16
HRP20110046T1 (hr) 2011-03-31
PL1720610T3 (pl) 2011-04-29
DE602005025313D1 (de) 2011-01-27
US20070218106A1 (en) 2007-09-20
UA88780C2 (uk) 2009-11-25
EP1720610B1 (en) 2010-12-15
AU2005211936A1 (en) 2005-08-25
SI1720610T1 (sl) 2011-02-28
CA2555099A1 (en) 2005-08-25
CN1946456A (zh) 2007-04-11
EA200601385A1 (ru) 2007-02-27
JP2013135686A (ja) 2013-07-11
EA011721B1 (ru) 2009-04-28
WO2005077464A1 (en) 2005-08-25
DK1720610T3 (da) 2011-02-21
KR20070034459A (ko) 2007-03-28
CN1946456B (zh) 2011-11-09
EP1720610A1 (en) 2006-11-15
JP2007522254A (ja) 2007-08-09
ATE491497T1 (de) 2011-01-15
CA2555099C (en) 2013-02-05
ES2355905T3 (es) 2011-04-01
PT1720610E (pt) 2011-02-10
AU2005211936B2 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
CY1111112T1 (el) Συνθεση επιβραδυνσης του μεταβολισμου της αλκοολης
Shay et al. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential
Koklesova et al. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
McRae Betaine supplementation decreases plasma homocysteine in healthy adult participants: a meta-analysis
Loscalzo Oxidative stress in endothelial cell dysfunction and thrombosis
Samaras et al. Effect of a special carbohydrate–protein bar and tomato juice supplementation on oxidative stress markers and vascular endothelial dynamics in ultra-marathon runners
AR074990A1 (es) Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
Joseph et al. Quo vadis: whither homocysteine research?
Li et al. Deuterium and neutrophil kinetics
MX2007002689A (es) 7-azaindoles y su uso como agonistas de ppar.
Boadi et al. Effect of quercetin, genistein and kaempferol on glutathione and glutathione-redox cycle enzymes in 3T3-L1 preadipocytes
CY1108314T1 (el) Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματος
Jeong et al. β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells
Magdaleno et al. The involvement of glutamate metabolism in the resistance to thermal, nutritional, and oxidative stress in Trypanosoma cruzi
PL1753309T3 (pl) Kompozycje spożywcze zawierające kreatynę
Arslan et al. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid
Chaturvedi et al. NAD+: A big player in cardiac and skeletal muscle remodeling and aging
Prashanth et al. The beneficial effect of Coenzyme Q in diabetic neuropathy: An overview
EP3257497B1 (en) Antioxidant agent, antioxidant cosmetic and uv care cosmetic based on enzymatically synthesized glycogen or an alpha-amylase digest thereof
Liu et al. The Application of Nicotinamide Coenzymes and Precursors
Edwardsa et al. dexamethasone-induced atrophy in skeletal muscle cells
MX2014013800A (es) Sistema de energia comestible.
Tyagi High Fat Diet Induces Epigenetic 1-Carbon Metabolism and HFpEF
Thaler Vitamin C as an Epigenetic Gatekeeper of Osteogenesis and Skeletal Health–a New Perspective on an Ancient Molecule
CN113521208A (zh) 一种用于治疗高同型半胱氨酸血症的组合物